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 PHONE AND VIDEO-BASED MODALITIES OF CENTRAL BLINDED 
ADJUDICATION OF MODIFIED RANKIN SCORES IN AN ENDOVASCULAR 
STROKE TRIAL 
 
Abstract 
 
Background and purpose: The standard outcome measure in stroke research is modified Rankin 
Scale (mRS) evaluated by local blinded investigators. We aimed to assess feasibility and reliability 
of two central adjudication methods of mRS in the setting of a randomized endovascular stroke 
trial. 
 
Methods: This is a secondary analysis derived from the REVASCAT trial cohort. Primary outcome 
was distribution of mRS at 90 days. Local evaluation was done by certified investigators masked to 
treatment assignment using structured face-to-face interviews. In addition, central assessment was 
performed by two independent raters via structured phone interview (n=120) and via video-
recordings of the face-to-face interviews with local investigators (n=106). Interrater agreement was 
evaluated using kappa and discordance statistics. Sensitivity analyses for the primary endpoint 
using different adjudication approaches were performed. Correlation between mRS obtained with 
each modality and 24 hour follow-up infarct volumes (FIV) was studied. 
 
Results: Using local evaluation as the reference, higher agreement rates were noted with central 
video than with central phone evaluations (kw 0.92[0.88-0.96] versus 0.77[0.72-0.83]). 
Discrepancies in mRS scoring between local and central raters (phone and video-based) were 
similar in both treatment allocation arms. Sensitivity analyses showed benefit of endovascular 
treatment irrespective of adjudication method, but higher odds ratios were observed with local 
evaluations. FIV was similarly correlated with mRS across all three evaluation modalities. 
 
Conclusion: Central adjudication of mRS is feasible, reducing interrater variability and avoiding 
potential problems related to lack of blinding. Our findings may have implications in the planning 
of future randomized acute stroke trials, especially in those including non-pharmacological 
interventions. 
 
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01692379  
 
Introduction 
 
The modified Rankin scale (mRS), the standard outcome measure in acute stroke research, 
is usually assessed by local blinded investigators through in person encounters1. Although 
core labs for adjudication of secondary end points (eg. imaging) are frequently used in 
stroke research, central adjudication of mRS scores is less commonly used. There is a 
substantial interobserver variability in mRS assessment that persists even with certified 
assessors and using structured interviews2,3,4.  For open label trials such as procedure based 
stroke studies, an additional shortcoming is the difficulty of local investigators to remain 
blinded to treatment allocation. 
 
Central or external evaluation of functional outcome may overcome these limitations. 
Telephonic interviews assessing mRS have shown a modest agreement with face-to-face 
interviews in exploratory studies 5, 6, and this agreement has not been assessed properly in a 
clinical trial setting. Recently, Mc Arthur and colleagues published the feasibility and 
reliability of a video-based modality for central remote mRS adjudication in a virtual 
multicenter stroke trial using a group adjudication approach with four central assessors 7. 
Agreement between the centrally adjudicated and local evaluations was good. They also 
demonstrated the feasibility of using translated interviews simulating an international 
multicenter study. However, the use of external video-based adjudication methodology in a 
real-world trial has not been published yet. 
In order to address the above mentioned concerns related to in person evaluation, 
REVASCAT (Randomized Trial of Revascularization with Solitaire FR® device versus 
Best Medical Therapy in the Treatment of Acute Stroke due to Anterior Circulation Large 
Vessel Occlusion Presenting within Eight Hours of Symptom Onset) was designed to 
include both local and central evaluation methods of the primary outcome. This secondary 
analysis from REVASCAT study aimed to determine feasibility of central mRS 
adjudication and compare different central adjudication methods (phone and video-based). 
In addition, since the true disability status cannot be determined, the three methods of 
outcome adjudication were also compared with a more objective measure of cerebral 
impairment, core lab evaluated 24 hour infarct volume on CT or MRI scans. 
 
 
Methods 
Study design 
REVASCAT enrolled 206 patients, randomized to thrombectomy with Solitaire device 
versus medical management alone. Eligible patients had contraindications to IV alteplase or 
had received IV alteplase therapy within 4.5 hours without revascularization after 30 
minutes of alteplase infusion. Primary endpoint was distribution of mRS scores at 90 days 
(±14 days).  Details on study protocol and main results of the study have been already 
published8,9. 
 
Modified Rankin scale evaluations 
The primary outcome variable was evaluated twice in each patient by both local and central 
certified assessors. Locally, each site designated one or more mRS-certified neurologists, 
not involved in patient management, to evaluate the mRS score in a face-to-face visit. Local 
investigators were asked to follow a specific structured interview based on the Rankin 
Focused Assessment 10.  
Methodology for central adjudication of mRS scores varied along REVASCAT study 
enrolment: during the first period of the study an external mRS-certified nurse (MS) 
evaluated mRS scores by telephone call using the same structured interview as local 
investigators and recorded the interviews by audio-tape. After 50 patients centrally 
adjudicated in this manner, based on a pre-determined unblinded safety analysis, the DSMB 
recommended implementing measures that would result in a higher concordance between 
local and centrally adjudicated outcomes. For that reason the steering committee decided to 
implement a remote video-based adjudication of mRS. After the approval of the ethical 
committee of each center, the local face-to-face structured interviews were video recorded 
and stored in a specific laptop equipped with a portable web-cam and internet connection 
that was distributed to each center with this purpose. Video-clips were uploaded and 
transferred via file transfer protocol (FTP) to one single external, mRS-certified neurologist 
(JS). For the ensuing 55 patients and in order to ensure continuity of central assessments in 
case the video evaluation proved to be unfeasible, both central video and central audio 
evaluations were performed. Central assessors were located outside the enrolling hospitals, 
were not aware of mRS scores given by local investigators, and introduced their 
assessments in an independent part of eCRF.  
Central video rater also evaluated, in a blinded-manner, quality of face-to-face interviews 
performed by local investigators and scored them as: 1. Poor (local investigator did not 
follow structured interview systematically, central rater had to display video-clip more than 
two times to decide on a final assessment); 2. Acceptable (structured interview is used but 
central rater has some uncertainties in evaluation between two adjacent items, having to 
view part of the video-clip at least twice); 3. Reliable (structured interview is completely 
followed and central rater has no hesitation in ascribing a final adjudication after reviewing 
video-clip only once). 
 
Final infarct volume measurement 
Infarct volumes at 24 hours on CT or MRI were adjudicated blinded to clinical data by 
image core lab. In case both CT and MRI were available, for uniformity sake CT data was 
used. Volumes were calculated through software generated volumetric calculations 
(Quantomo, 11) with manual adjustments when deemed necessary. In case of coexistence of 
hemorrhage and infarction, combined (infarction and hemorrhage) volumes were used. 
 
Statistical analysis  
Global inter-rater agreement in mRS scoring between local and central raters was evaluated 
with weighted kappa statistics. Magnitude and direction of discrepancies (difference 
between central rater and local rater) were also studied. In order to detect possible bias 
regarding lack of blinding, those discrepancies were compared between both treatment 
allocation arms with T test, as sample size was big enough to employ convergence to 
Normal distribution. First, discrepancies were evaluated globally between local and central 
raters, including phone and video-based raters (in the 55 patients with both central 
assessments, the average score [phone+video]/2 was used). Thereafter, due to the different 
methodology between phone and video-based evaluations, discrepancies of local 
investigators with each of central assessors was evaluated also separately. All analyses 
were performed excluding deaths (mRS=6). In patients evaluated by the central video-
based rater, percentage of total agreement with local evaluations was also studied taking 
into account quality of interviews (poor, acceptable, reliable).  
Primary analysis in REVASCAT was based on central evaluator through video recording 
with local investigator’s assessment as the default modality in case the video evaluation 
was not available as per steering committee decision prior to data unblinding. Sensitivity 
analyses for the main outcome were also performed based on scores given by both central 
evaluators (sensitivity analysis I) and local investigators (sensitivity analysis II). All 
analyses were in the intention-to-treat population. Effect size measure was a cumulative 
logistic regression odds ratio (shift analysis) and 95% confident interval, adjusted for 
minimization factors and IV alteplase use.   
Correlation (Spearman) of final infarct volume with mRS scores obtained with each of the 
three mRS assessments was performed. 
 
Results 
From November 2012 to December 2014, 206 patients were enrolled in REVASCAT trial 
in four centers in Catalonia, Spain. All patients had available outcomes at 90 days 
performed via at least two methods. Excluding deaths, 171 patients had an evaluation of 
mRS at 90 days performed by masked local investigators at each site (in 5 patients the local 
evaluation was made by phone due to patient’s impossibility to attend the hospital). During 
the first period of the study, 120 patients also underwent a central phone based assessment 
of functional status at 90 days. In the second part of the study, 106 patients were video-
recorded during the face-to-face interviews at local sites, and a single central assessor 
evaluated mRS in video-recordings. There were 55 patients that received all three 
evaluations (local, phone-based and video-based).  
 
Feasibility of central adjudication of mRS during the trial 
All patients or proxies consented to mRS evaluation by any method, anonymity was 
maintained in all patients and the files containing the functional assessment (audio and 
video clips) were stored as back-up copies. For central phone adjudication, a notification 
was sent via fax to the central evaluator including the name of the patient and a direct 
relative, contact phones and the date to be called after randomization. Phone calls were 
made from a central office of the Catalan Stroke Program. Remote video-based assessment 
required the implementation of specific technology in the four participating centers 
consisting on a light laptop equipped with web-cam and internet connectivity to directly 
store the video-clips and afterwards upload them to the transmission system.  The 
portability of the laptop facilitated that the interviews could be made in any outpatient 
office. Video protocol was brief and no technical issues were encountered with respect to 
recording, storing or uploading the video-files. The FTP allowed secure transfer of video 
files to the central assessor. Following the protocol, there were no need to edit the video-
files and the entire process including set-up and transmission took no longer than a few 
minutes per case. 
 
Agreement between local investigators and central assessors  
The cross-tabulation of pair ratings by local investigators and central assessors is 
represented in Table 1. The percentage of total agreement (diagonal cells) was higher using 
video-based assessments than phone-based assessments for all mRS scores. Globally, total 
agreement between local and central assessor was obtained in 62.5% of cases (95% CI, 
53.2-71.2), kw= 0.77 (95% CI, 0.72-0.83) using phone calls and in 86.8% of cases (95% CI, 
78.8-92.6), kw=0.92 (95% CI, 0.88-0.96) using video recordings. In the group of 55 patients 
that received both central assessments, agreement between both central raters was 67.3% 
(95% IC 53.3 - 79.3), kw= 0.78 (95% CI, 0.69-0.88). Compared to local investigator, phone 
assessor gave a lower score in 22.5% and a higher score in 15% of cases; video-assessor 
gave a lower or higher score in the same percentage of cases (6.6%), compared to local 
investigator. 
Magnitude and direction of discrepancies in each treatment arm is represented in Table 2. 
Globally, mean difference in mRS scoring between local and central raters (phone and 
video-based) was comparable regardless of treatment allocation (p= 0.3466) but differed in 
those patients evaluated by video-recordings (p=0.0075). Percentage of direction of 
discrepancies is represented in Table 3.  
 Quality of local mRS interviews as assessed by the central video-based assessor 
Quality of local face-to-face interviews as assessed by central video evaluator were poor in 
11/106 cases (10.4%), acceptable in 19/106 cases (17.9%) and reliable in 76/106 (71.7%). 
The higher the quality of face-to-face interviews, the better the agreement between video-
based central assessor and local investigator (36.4%, 84.2% and 92.1% for poor, acceptable 
and reliable clips respectively). Percentage of poor quality interviews was higher in the first 
period after implementation of video-recordings compared to the last period (13.3% versus 
7.2%). 
 
 
Sensitivity analyses for the primary outcome of REVASCAT trial 
Sensitivity analyses for primary outcome of REVASCAT trial using different adjudication 
methods of final mRS scores are represented in Figure 1. All analyses showed benefit of 
endovascular treatment but odds ratio slightly differed, being higher when using local 
evaluations. 
 
Association of final infarct volume and mRS scores 
Spearman correlation coefficients between FIV and mRS scores were similar among the 
three adjudication methods in the group of 55 patients that underwent all evaluations, but 
differed slightly between treatment arms with local ratings (Table 4).  
 
 
Discussion 
We evaluated two different methods of central mRS adjudication within an acute stroke 
endovascular trial. Both modalities, phone and video-based, were found to be feasible, with 
no patient compliance related issues or concerns about breach of confidentiality.  Central 
blinded adjudication of mRS provided quality control of mRS interviews at local sites and 
avoided potential bias regarding blinding. In addition, files containing functional 
assessment (audio and video clips) were available and stored as back-up copies which 
represent an advantage if outcomes are desired to be reanalyzed centrally for the purposes 
of pooled analyses or for the purposes of conducting analyses using different endpoints.  
 
Reliability of central adjudication was evaluated assessing inter-rater agreement of central 
assessors with face-to-face evaluations at local sites, the latter being generally considered 
the standard methodology. Agreement was good for both modalities, but it was higher with 
video-based adjudication than phone-based adjudications. Agreement between local and 
central video assessors was also higher compared to CARS study7, probably due to the 
disagreements between the adjudication committee members in CARS study, which 
occurred in more than 50% of evaluations. Furthermore, in our relatively small sample size, 
agreement between local and video-based assessors was 100% for mRS scores 0, 3 and 4.  
Phone assessor gave lower scores (corresponding to lower disability states) than local 
investigators more frequently than video-based assessor. This may be explained by the fact 
that central video rater is reviewing the assessment that was performed at the same point in 
time and in the same environment as the local investigator, receiving exactly the same 
information from the patient and proxy (if present); this is not the case with phone 
adjudication which was performed at different time points. In addition, for those patients 
who are too disabled to provide the information themselves, questions may have been 
answered by a different proxy. Importantly, the central video assessor is able to observe and 
evaluate patient global status and some abilities (e.g walking) directly while phone assessor 
is not. Furthermore behavioral aspects of stroke recovery such as neglect, anosognosia with 
impact on patient’s account of their ability to function can be better assessed by direct 
visual assessment.  
 
Another advantage of central video-based adjudication is that it provides quality control of 
face-to-face interviews performed at local sites. Although there were no video-clips unable 
to be scored, agreement was better when local investigators followed correctly the 
structured interview, as mandated by the study protocol. In case an investigator was not 
performing mRS assessment properly as judged by the central assessor, feed-back could be 
given to local sites to improve training of local investigators for future interviews. Indeed, 
we observed a reduction in poor quality interviews across the study. Ideally, the expert 
feed-back should be given in real time allowing the investigators to re-perform the 
interview following the central assessor advice. Therefore, the possibility of schedule the 
out-patient visit with availability of central assessor to perform the evaluation in real time 
would be of great interest. This could be implemented in future studies thanks to the advent 
of new technologies as high speed internet, two-way video conferencing and the ubiquitous 
use of smart phones. 
 
The few observed disagreements between video assessor and local investigators are to be 
expected given the inherent interrater variability of this adjudication method12. However, 
we must be alert for potential bias due to lack of blinding within endovascular stroke trials 
in which treatment allocation is open.  Therefore, we compared disagreement between local 
and central raters in both treatment arms. While not significant differences were noted in 
the whole cohort, in the group of patients evaluated by video, mean differences in mRS 
scoring varied among treatment arms and were in the direction of benefit of endovascular 
treatment. Although the reason for these observed discrepancies is unclear, there is a 
possibility that these differences may in part be explained by lack of blinding by evaluators 
working at recruiting centers.  
 
The statistical analysis plan in REVASCAT study did not a priori establish which of the 
three outcome adjudication methods will be the main method used for the primary outcome. 
Based on the unequivocally blinded nature of the central video adjudication in conjunction 
with high inter-rater reliability rates between local adjudications and central video 
adjudications, prior to the first interim analysis the blinded steering committee of 
REVASCAT decided to consider the central video analysis as primary method used for 
endpoint adjudication with local evaluation used as default method in case the former was 
missing. Sensitivity analyses were pre-planned using different adjudication methods for 
mRS. These analyses reflected the effect of selecting different endpoint adjudication 
methods on trial results. Had local mRS assessments been chosen as primary outcome 
adjudication method, the treatment effect of endovascular treatment in REVASCAT would 
have been higher than reported.  
 
Because all three measurement methods are prone to errors and the true disability status of 
each patient cannot be ascertained with certainty we sought to validate these three distinct 
ways of obtaining the mRS against another more objective variable that is known to 
strongly correlate with neurological recovery, which is 24 hour infarct volume 13. We found 
similar and good degree of correlation across all evaluation modalities that did not favor 
any of the evaluation methods. 
 
The main limitation of the present study is that central adjudication modalities varied along 
the study (phone in the first period and video in the last), and only 55 patients received both 
central evaluations. This fact prevented direct comparisons between the two central 
assessors in the whole cohort and hampered sensitivity analyses of primary outcome of the 
trial using only one central adjudication method. Also, having the three adjudication 
methods in the whole cohort of 206 patients would have improved the results statistically 
and also avoided the problem of unequal numbers in each group. Another limitation is that 
being only one central assessor in each modality we cannot be certain whether the findings 
apply to a rating pattern of particular central assessors; however, it represents also a 
strength point due to the elimination of interobserver variability among different central 
assessors.  
In summary, central adjudication of mRS using video-recordings is feasible and easy to 
implement in a stroke trial setting, improving quality of assessment of primary outcome 
and avoiding potential bias.  In addition, it confers the advantage of permanent data 
recording. These results should be considered in the planning of future randomized acute 
stroke trials, especially in those with open treatment allocation.  
 
 
Sources of funding 
REVASCAT was funded by a local independent Catalan institution (Fundació Ictus 
Malaltia Vascular, www.fundacioictus.com/es) by means of an unrestricted grant from the 
manufacturer of the device (Covidien). This project has been partially supported by a grant 
from the Spanish Ministry of Health co-financed by FEDER (Instituto de Salud Carlos III, 
RETICS-INVICTUS, RD 12/0014/008). 
 Disclosures 
None 
  
 References 
1.  Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in 
contemporary stroke trials. Int. J. Stroke. 2009;4:200–205.  
2.  Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified rankin scale: 
A systematic review. Stroke. 2009;40:3393–3395.  
3.  Wilson JTL, Hareendran A, Hendry A, Potter J, Bone I, Muir KW. Reliability of the 
modified Rankin Scale across multiple raters: Benefits of a structured interview. 
Stroke. 2005;36:777–781.  
4.  Quinn TJ, Lees KR, Hardemark HG, Dawson J, Walters MR. Initial experience of a 
digital training resource for modified Rankin Scale assessment in clinical trials. 
Stroke. 2007;38:2257–2261.  
5.  Janssen PM, Visser NA, Dorhout Mees SM, Klijn CJM, Algra A, Rinkel GJE. 
Comparison of telephone and face-to-face assessment of the modified Rankin Scale. 
Cerebrovasc. Dis. 2010;29:137–139.  
6.  Savio K, Pietra GL Della, Oddone E, Reggiani M, Leone MA. Reliability of the 
modified Rankin Scale applied by telephone. Neurol. Int. 2013;5:6–7.  
7.  McArthur KS, Johnson PCD, Quinn TJ, Higgins P, Langhorne P, Walters MR,et al. 
Improving the efficiency of stroke trials: Feasibility and efficacy of group 
adjudication of functional end points. Stroke. 2013;44:3422–3428.  
8.  Molina C, Chamorro A, Rovira À, de Miquel A, Serena J, Roman LSet al. 
REVASCAT: A randomized trial of revascularization with SOLITAIRE FR® device 
vs. best medical therapy in the treatment of acute stroke due to anterior circulation 
large vessel occlusion presenting within eight-hours of symptom onset. Int. J. Stroke. 
2015;10: 619–26.  
9.  Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al. 
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J 
Med. 2015; 372:2296-306.  
10.  Saver JL, Filip B, Hamilton S, Yanes A, Craig S, Cho M et al. Improving the 
reliability of stroke disability grading in clinical trials and clinical practice: The 
rankin focused assessment (RFA). Stroke. 2010;41:992–995.  
11.  Kosior JC, Idris S, Dowlatshahi D, Alzawahmah M, Eesa M, Sharma P et al. 
Quantomo: validation of a computer-assisted methodology for the volumetric 
analysis of intracerebral haemorrhage. Int. J. Stroke. 2011;6:302–305.  
12.  Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the Reliability of the 
Modified Rankin Scale. Stroke. 2009;40:762–766.  
13.  Rangaraju S, Liggins JTP, Aghaebrahim A, Streib C, Sun CH, Gupta R et al. 
Pittsburgh outcomes after stroke thrombectomy score predicts outcomes after 
endovascular therapy for anterior circulation large vessel occlusions. Stroke. 2014; 
45: 2298–2304.  
 
 
 
  
Figure legend 
Figure 1. Sensitivity analyses for primary outcome of the trial (mRS shift) using different 
adjudication methods.  
  
  
 
 
 
Table 1. Cross-tabulation of pair ratings of mRS by local investigators and central 
assessors  
  
 
Local evaluation (face-to-face interview) 
Central phone (n=120)   0 1 2 3 4 5 
  0 n (%) 4 ( 80.0%) 7 ( 28.0%) 1 (  4.0%)       
  1 n (%) 1 ( 20.0%) 11 ( 44.0%) 8 ( 32.0%)       
  2 n (%)   7 ( 28.0%) 12 ( 48.0%) 5 ( 20.0%)     
  3 n (%)     4 ( 16.0%) 19 ( 76.0%) 2 ( 13.3%) 2 (  8.0%) 
  4 n (%)       1 (  4.0%) 8 ( 53.3%) 2 (  8.0%) 
  5 n (%)         5 ( 33.3%) 21 ( 84.0%) 
Central video-recording (n=106)   0 1 2 3 4 5 
  0 n (%) 7 (100.0%) 4 ( 20.0%)         
  1 n (%)   12 ( 60.0%)         
  2 n (%)   3 ( 15.0%) 17 ( 85.0%)       
  3 n (%)   1 (  5.0%) 3 ( 15.0%) 24 (100.0%)     
  4 n (%)         11 (100.0%) 3 ( 12.5%) 
  5 n (%)           21 ( 87.5%) 
  
  
Table 2. Magnitude of discrepancies among each treatment arm 
 Endovascular arm Medical arm 
Difference mRS (central - 
local)* 
n 84 87 
 Mean (SD) 0.00 (0.51) -0.07 (0.53) 
 Min, Max -1.5, 1.0 -1.0, 1.0 
 p-value 0.3466  
    
Difference mRS (central 
phone- local) 
n 57 63 
 Mean (SD) -0.12 (0.60) -0.08 (0.73) 
 Min, Max -2.0, 1.0 -2.0, 1.0 
 p-value 0.7229  
    
Difference mRS (central 
video- local) 
n 55 51 
 Mean (SD) 0.11 (0.46) -0.10 (0.30) 
 Min, Max -1.0, 2.0 -1.0, 0.0 
 p-value 0.0075  
Difference in mRS scores between central rater and local rater. *Central included phone and video-based. In those patients 
assessed by the two central raters the average score [(phone+video)/2] was used. Mean (SD) represent mean of the 
difference in mRS scoring (Standard Deviation). Min=minimum difference. Max: maximum difference. P-value is the 
result of Student T test for the mean differences in scoring between arms  
Table 3. Direction of discrepancies between local and central raters in each treatment arm 
 
Endovascular 
treatment Medical arm 
 n 84 87 
  Local scores lower than central n (%) 12 ( 14.3%) 12 ( 13.8%) 
  Same rating n (%) 60 ( 71.4%) 56 ( 64.4%) 
  Local scores higher than central n (%) 12 ( 14.3%) 19 ( 21.8%) 
 p 0.4346  
Central scores included phone and video-based. In those patients with both scores the average central score 
[(phone+video)/2] was used. 
  
  
Table 4. Correlation coefficients (Spearman) between final infarct volume (FIV) and mRS 
scores 
 All patients (n=55)*  Endovascular arm (n=28) Medical arm (n=27) 
Local  0.458  0.331 0.453 
Central phone  0.471  0.399 0.426 
Central video 0.472  0.401 0.437 
*For this analysis only patients with the three evaluations (local, phone and video) were selected to enable 
comparison of coefficients (same infarct volumes) 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
